社区

Looking for some year-end deals on top stocks for 2022? Look no further.

- Wall Street finished lower on Friday, weighed down by Big Tech as investors worried about the Omicron coronavirus variant and digested the Federal Reserve's decision to end its pandemic-era stimulus faster.All three main U.S. stock indexes ended with a decline for the week after the Fed on Wednesday signaled three quarter-percentage-point interest rate hikes by the end of 2022 to combat surging inflation.Nvidia dropped 2.1% and Alphabet lost 1.9%, both weighing on the S&P 500 and Nasdaq.The S

U.S. Stock futures headed for a lower open Friday morning after a rout in technology stocks during T

Roblox slid over 10% in morning trading as it broke the growth momentum for six consecutive months.I

The main event for investors this week will be the Federal Reserve’s rate-setting committee’s last meeting of 2021. Recent commentary from officials has leaned more hawkish, setting up a potential announcement of plans to accelerate monthly asset purchase tapering.The Federal Open Market Committee’s two-day meeting takes place on Tuesday and Wednesday.Earnings reports this week are few, but will include Campbell Soup on Tuesday;Lennar,Accenture,FedEx,Rivian Automotive, and Adobe on Thursday; and

The IPO market is expected to stay relatively quiet in the week ahead with three IPOs scheduled to r

Wall Street closed slightly higher on Wednesday with the three major indexes managing their third st

Shares of NXP Semiconductors fell 5% Wednesday after UBS initiated coverage on the stock with a Sell

Dec 6 - Wall Street's major averages closed higher on Monday with economically sensitive sectors and travel-related stocks advancing solidly as investors were encouraged by some optimistic comments from a top U.S. official on the latest COVID-19 variant.Of Wall Street's three major averages, the Dow rose the most while industrials and consumer staples , up around 1.6%, were the S&P's strongest sectors followed by energy and utilities , up 1.5%. But declines in COVID-19 vaccine companies diminis